Who should be prioritised for COVID-19 vaccination?

被引:53
|
作者
Russell, Fiona M. [1 ,2 ]
Greenwood, Brian [3 ]
机构
[1] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Asia Pacific Hlth Res, Melbourne, Vic, Australia
[3] London Sch Hyg & Trop Med, Dept Dis Control, London, England
基金
英国医学研究理事会;
关键词
COVID-19; vaccines; high-risk; epidemiology; transmission; vaccine development; clinical trials; WOMEN;
D O I
10.1080/21645515.2020.1827882
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
引用
收藏
页码:1317 / 1321
页数:5
相关论文
共 50 条
  • [1] Should COVID-19 vaccination be mandatory?
    Ariel Franco, Juan Victor
    BMJ EVIDENCE-BASED MEDICINE, 2021, 26 (06) : 269 - 270
  • [2] How frequent are acute reactions to COVID-19 vaccination and who is at risk?
    Dreyer, Nancy
    Reynolds, Matthew W.
    Albert, Lisa
    Brinkley, Emma
    Kwon, Tom
    Mack, Christina
    Toovey, Stephen
    VACCINE, 2022, 40 (12) : 1904 - 1912
  • [3] Progress with COVID-19 vaccination in the WHO African Region in 2021
    Masresha, Balcha
    Poy, Alain
    Weldegebriel, Goitom
    Mbuyita, Selemani
    Fussum, Daniel
    Bwaka, Ado
    Paluku, Gilson
    Atuhebwe, Phionah
    Mihigo, Richard
    Impouma, Benido
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [4] Pregnancy and COVID-19: prevention, vaccination, therapy, and beyond
    Sahin, Dilek
    Tanacan, Atakan
    Webster, Sophia Ne
    Tekin, Ozlem Moraloglu
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 : 3312 - 3326
  • [5] Should Cancer Patients be Prioritized for Covid-19 Vaccination?
    Mardani, Masoud
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2020, 15 (06):
  • [6] Healthcare students: should they be prioritized for COVID-19 vaccination?
    Riva, Michele Augusto
    Paladino, Maria Emilia
    Belingheri, Michael
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 124 - 125
  • [7] Necessity of Coronavirus Disease 2019 (COVID-19) Vaccination in Persons Who Have Already Had COVID-19
    Shrestha, Nabin K.
    Burke, Patrick C.
    Nowacki, Amy S.
    Terpeluk, Paul
    Gordon, Steven M.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E662 - E671
  • [8] COVID-19 in pregnancy
    Greer, Orene
    Saeed, Zainab
    Woon, Ee Von
    Singh, Natasha
    Johnson, Mark
    Shah, Nishel
    OBSTETRICIAN & GYNAECOLOGIST, 2025, 27 (01) : 43 - 56
  • [9] Impact of COVID-19 and its vaccination in pregnancy
    Reynoso, Rebeca Gonzalez
    Valencia-Ortega, Jorge
    Saucedo, Renata
    CIENCIA ERGO-SUM, 2024, 31
  • [10] COVID-19 Vaccination and Pregnancy
    Ignaszak-Kaus, Natalia
    Chmaj-Wierzchowska, Karolina
    Wszolekl, Katarzyna
    Wilczak, Maciej
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (10)